cas 2756-85-6|| where to buy 1-Aminocyclohexane-1-carboxylic acid

Product Name:1-Aminocyclohexane-1-carboxylic acid

IUPAC Name:1-aminocyclohexane-1-carboxylic acid

Packing Unit	Available Stock	Price($)
CM203211-25g	in stock	ȡƥ
CM203211-100g	in stock	Ǒǫȯ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Additional Notes

Verification code*

refresh

: CAS NO:2756-85-6; Molecular Formula:C7H13NO2; Melting Point:-; Smiles Code:O=C(C1(N)CCCCC1)O; Density:

: Catalog Number:CM203211; Molecular Weight:143.19; Boiling Point:272.3±23.0°C at 760 mmHg; MDL No:MFCD00001487; Storage:Store at 2-8°C.

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: Cyclohexanes; Cyclohexane is an organic compound with a chemical formula C6H12. It is a colorless liquid with a pungent odor, insoluble in water, and soluble in most organic solvents such as ethanol, ether, benzene, and acetone. Cyclohexyl fragments are a common structure in both natural and synthetic drugs. It can be used as both core structure and part of achiral side chain.

: INX-315; Incyclix Bio announces FDA clearance of investigational new drug application for INX-315 in patients with advanced or metastatic cancer. INX-315 is a novel, potent and selective inhibitor of Cyclin-dependent kinase 2 (CDK2) with compelling pre-clinical efficacy and safety data.
CDK2 is thought to play an important role in driving proliferation of certain cancers, including those harboring CCNE1 amplification and breast cancers that have acquired resistance to CDK4/6 inhibitors (CDK4/6i).